A similar pattern of hemostatic markers was observed in the present analysis at day 1: PT, antithrombin activity, and fibrinogen in the COVID-19 group were almost within normal range and significantly higher compared with the values in the non-COVID-19 group. This evidence concerns the gene F2 and COVID-19.